Detalhe da pesquisa
1.
Long-term follow-up of contemporary drug-eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial.
Catheter Cardiovasc Interv
; 101(3): 505-510, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651339
2.
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention.
Neth Heart J
; 31(11): 426-433, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713051
3.
Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
Catheter Cardiovasc Interv
; 99(2): 366-372, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811730
4.
Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions.
Catheter Cardiovasc Interv
; 97(2): 247-256, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999077
5.
Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
Circulation
; 139(1): 67-77, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586704
6.
Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
Catheter Cardiovasc Interv
; 91(3): 410-416, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28544782
7.
Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study.
Front Cardiovasc Med
; 9: 932799, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911523
8.
High bleeding risk in patients undergoing percutaneous coronary intervention with drug-eluting stent implantation: ReCre8 subanalysis.
Am Heart J Plus
; 24: 100227, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38560639
9.
Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial.
Eur Heart J Cardiovasc Pharmacother
; 8(1): 4-12, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730628
10.
3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent: ReCre8 Landmark Analysis.
JACC Cardiovasc Interv
; 14(22): 2477-2486, 2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794654
11.
Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model.
Am J Physiol Heart Circ Physiol
; 299(2): H310-21, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20435847
12.
Dominant arrhythmia vulnerability of the right ventricle in senescent mice.
Heart Rhythm
; 5(3): 438-48, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18313604
13.
Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry.
Cardiovasc Revasc Med
; 19(5 Pt A): 521-525, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29137966
14.
Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging.
Circulation
; 112(13): 1927-35, 2005 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-16172272
15.
Spatial Heterogeneity of Cx43 is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias during Compensated Cardiac Hypertrophy in Rats.
Front Cardiovasc Med
; 3: 5, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26973841
16.
Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice.
Heart Rhythm
; 9(4): 600-7, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22100711
17.
A 50% reduction of excitability but not of intercellular coupling affects conduction velocity restitution and activation delay in the mouse heart.
PLoS One
; 6(6): e20310, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673812
18.
Three-dimensional anatomic structure as substrate for ventricular tachycardia/ventricular fibrillation.
Heart Rhythm
; 2(7): 777-9, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15992738
19.
Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias.
Eur J Heart Fail
; 12(9): 913-21, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534605
20.
Combined reduction of intercellular coupling and membrane excitability differentially affects transverse and longitudinal cardiac conduction.
Cardiovasc Res
; 83(1): 52-60, 2009 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389723